Between 2013 and 2023, Indonesia's market size value per capita for hormones in dosage (excluding contraceptives and antibiotics) has generally trended upwards. In 2023, the value stood at $0.84. There was a steady increase from 2018 to 2021, with only a slight dip in 2022 before returning to its previous peak in 2023. The average annual growth rate (CAGR) over the last five years is indicative of a consistent upward trend.
Looking forward, potential growth factors include increased healthcare access and awareness, driving further demand for hormonal therapies. Market observers should monitor regulatory changes and advancements in medical technologies as they might influence future market dynamics.
